These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38762019)

  • 21. The risk of recurrent venous thromboembolism in patients with unprovoked symptomatic deep vein thrombosis and asymptomatic pulmonary embolism.
    Jiménez D; Díaz G; Marín E; Vidal R; Sueiro A; Yusen RD
    Thromb Haemost; 2006 Mar; 95(3):562-6. PubMed ID: 16525588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inferior vena cava agenesis in patients with lower limb deep vein thrombosis in the RIETE registry. When and why to suspect.
    Tufano A; López-Jiménez L; Bikdeli B; García-Bragado F; Mazzolai L; Amitrano M; Gómez-Cuervo C; Marchena PJ; Madridano O; Monreal M; Di Micco P;
    Int J Cardiol; 2020 Apr; 305():115-119. PubMed ID: 31954590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in duration of anticoagulation after pulmonary embolism and deep vein thrombosis: Findings from the SWIss Venous ThromboEmbolism Registry (SWIVTER).
    Wenger N; Sebastian T; Beer JH; Mazzolai L; Aujesky D; Hayoz D; Engelberger RP; Korte W; Voci D; Kucher N; Barco S; Spirk D
    Thromb Res; 2022 Dec; 220():65-71. PubMed ID: 36272334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry.
    Riera-Mestre A; Mora-Luján JM; Trujillo-Santos J; Del Toro J; Nieto JA; Pedrajas JM; López-Reyes R; Soler S; Ballaz A; Cerdà P; Monreal M;
    Orphanet J Rare Dis; 2019 Aug; 14(1):196. PubMed ID: 31399146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Characteristics and Outcomes of Patients with Lung Cancer and Venous Thromboembolism.
    Ruiz-Artacho P; Trujillo-Santos J; López-Jiménez L; Font C; Díaz-Pedroche MDC; Sánchez Muñoz-Torrero JF; Peris ML; Skride A; Maestre A; Monreal M;
    TH Open; 2018 Apr; 2(2):e210-e217. PubMed ID: 31249944
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical characteristics and outcomes of venous thromboembolic events after hallux valgus surgery: insights from the RIETE registry.
    Bikdeli B; Visvanathan R; Weinberg I; Rivas A; Nieto JA; Sampériz Á; Loring M; Vázquez FJ; Yoo HHB; Bikdeli B; Monreal M
    J Thromb Thrombolysis; 2020 May; 49(4):651-658. PubMed ID: 31898272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of distal deep vein thrombosis.
    Kirkilesis G; Kakkos SK; Bicknell C; Salim S; Kakavia K
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD013422. PubMed ID: 32271939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Venous thromboembolism in centenarians: Findings from the RIETE registry.
    Lacruz B; Tiberio G; Núñez MJ; López-Jiménez L; Riera-Mestre A; Tiraferri E; Verhamme P; Mazzolai L; González J; Monreal M;
    Eur J Intern Med; 2016 Dec; 36():62-66. PubMed ID: 27495947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis.
    Tufano A; Ageno W; Di Micco P; Niglio A; Rosa V; Ballaz A; Braester A; Rubio CM; Isern V; Imbalzano E; Monreal M;
    Thromb Res; 2018 Apr; 164():69-74. PubMed ID: 29499439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism.
    Robertson L; Yeoh SE; Ramli A
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011088. PubMed ID: 29244199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.
    Robertson L; Strachan J
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD006771. PubMed ID: 28195640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting recurrences or major bleeding in cancer patients with venous thromboembolism. Findings from the RIETE Registry.
    Trujillo-Santos J; Nieto JA; Tiberio G; Piccioli A; Di Micco P; Prandoni P; Monreal M;
    Thromb Haemost; 2008 Sep; 100(3):435-9. PubMed ID: 18766259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism.
    Douketis JD; Gu CS; Schulman S; Ghirarduzzi A; Pengo V; Prandoni P
    Ann Intern Med; 2007 Dec; 147(11):766-74. PubMed ID: 18056660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Venous thromboembolism in solid-organ transplant recipients: Findings from the RIETE registry.
    García-Ortega A; López-Reyes R; Anguera G; Oscullo G; Rivas A; López-Jiménez L; Lorenzo A; Mahé I; Ciammaichella M; Monreal M;
    Thromb Res; 2021 May; 201():131-138. PubMed ID: 33684796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of recurrence after discontinuing anticoagulation in patients with COVID-19- associated venous thromboembolism: a prospective multicentre cohort study.
    Jara-Palomares L; Bikdeli B; Jiménez D; Muriel A; Demelo-Rodríguez P; Moustafa F; Villalobos A; López-Miguel P; López-Jiménez L; Otálora S; Peris ML; Amado C; Chopard R; Rivera-Cívico F; Monreal M;
    EClinicalMedicine; 2024 Jul; 73():102659. PubMed ID: 38828131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-Term Risk of Major Bleeding after Discontinuing Anticoagulation for Unprovoked Venous Thromboembolism: A Systematic Review and Meta-analysis.
    Khan F; Rahman A; Tritschler T; Carrier M; Kearon C; Weitz JI; Schulman S; Couturaud F; Becattini C; Agnelli G; Brighton TA; Lensing AWA; Pinede L; Parpia S; Geersing GJ; Takada T; Bradbury CA; Andreozzi GM; Palareti G; Prandoni P; Buller HR; Mallick R; Hutton B; Thavorn K; Le Gal G; Rodger MA; Fergusson DA
    Thromb Haemost; 2022 Jul; 122(7):1186-1197. PubMed ID: 34753191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Venous thromboembolism in young adults: Findings from the RIETE registry.
    Lacruz B; Tiberio G; Latorre A; Villalba JC; Bikdeli B; Hirmerova J; Lorenzo A; Mellado M; Cañas I; Monreal M;
    Eur J Intern Med; 2019 May; 63():27-33. PubMed ID: 30871951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis.
    Wang X; Ma Y; Hui X; Li M; Li J; Tian J; Wang Q; Yan P; Li J; Xie P; Yang K; Yao L
    Cochrane Database Syst Rev; 2023 Apr; 4(4):CD010956. PubMed ID: 37058421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis: a patient-level meta-analysis.
    Donadini MP; Ageno W; Antonucci E; Cosmi B; Kovacs MJ; Le Gal G; Ockelford P; Poli D; Prandoni P; Rodger M; Saccullo G; Siragusa S; Young L; Bonzini M; Caprioli M; Dentali F; Iorio A; Douketis JD
    Thromb Haemost; 2014 Jan; 111(1):172-9. PubMed ID: 24154729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High rate of recurrent venous thromboembolism in children and adolescents with unprovoked venous thromboembolism.
    Whitworth H; Clark HH; Hubbard RA; Witmer C; Leonard CE; Raffini L
    J Thromb Haemost; 2023 Jan; 21(1):47-56. PubMed ID: 36695395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.